Form 4: Sarepta Therapeutics Director Exercises Stock Options and Reports Beneficial Ownership

Director Richard Barry exercised stock options and reported changes in beneficial ownership of Sarepta Therapeutics, Inc. shares.

Summary

• On May 16, 2025, Richard Barry, a director of Sarepta Therapeutics, Inc., exercised stock options to acquire 12,350 shares of common stock at a price of $32.63 per share.
• Following this transaction, Barry directly owns 2,966,667 shares of common stock.
• Barry also indirectly owns 240,000 shares through a trust and 10,000 shares through an LLC.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of stock option exercise. It doesn't inherently indicate positive or negative performance.

Positives

• The exercise of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key individuals within a company.

Stakeholder Impact

• The transaction may have a minor impact on shareholders by slightly increasing the number of outstanding shares.

Key Dates

Keywords

Sarepta Therapeutics, Richard Barry, stock options, beneficial ownership, Form 4, director, SRPT